-+ 0.00%
-+ 0.00%
-+ 0.00%

CANDEL THERAPEUTICS ANNOUNCES NEW DATA SHOWING SUSTAINED IMMUNE REMODELING MORE THAN TWO YEARS AFTER AGLATIMAGENE BESADENOVEC TREATMENT IN LOCALIZED PROSTATE CANCER AT ASTRO 2026

Reuters·09/30/2026 12:05:00

Please log in to view news